Education
About Us
Working with TipRanks
Follow Us
OncoZenge AB (SE:ONCOZ)
:ONCOZ
ONCOZ Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr2.80 - kr12.10
Previous CloseN/A
Volume9.67K
Average Volume (3M)31.92K
Market Cap
kr62.78M
Enterprise ValueN/A
Total Cash (Recent Filing)kr3.86M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta2.02
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding11,713,244
10 Day Avg. Volume28,700
30 Day Avg. Volume31,916
Financial Highlights & Ratios
PEG Ratio-1.08
Price to Book (P/B)7.09
Price to Sales (P/S)0.00
P/FCF Ratio-8.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ONCOZ FAQ
What was OncoZenge AB’s price range in the past 12 months?
OncoZenge AB lowest stock price was kr2.80 and its highest was kr12.10 in the past 12 months.
What is OncoZenge AB’s market cap?
OncoZenge AB’s market cap is kr62.78M.
When is OncoZenge AB’s upcoming earnings report date?
OncoZenge AB’s upcoming earnings report date is May 20, 2025 which is tomorrow.
How were OncoZenge AB’s earnings last quarter?
OncoZenge AB released its earnings results on Feb 20, 2025. The company reported -kr0.214 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.214.
Is OncoZenge AB overvalued?
According to Wall Street analysts OncoZenge AB’s price is currently Overvalued.
Does OncoZenge AB pay dividends?
OncoZenge AB does not currently pay dividends.
What is OncoZenge AB’s EPS estimate?
OncoZenge AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoZenge AB have?
OncoZenge AB has 11,713,244 shares outstanding.
What happened to OncoZenge AB’s price movement after its last earnings report?
OncoZenge AB reported an EPS of -kr0.214 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.041%.
Which hedge fund is a major shareholder of OncoZenge AB?
Currently, no hedge funds are holding shares in SE:ONCOZ
---
Company Description
OncoZenge AB
OncoZenge AB is a Swedish pharmaceutical company focused on the development and commercialization of innovative treatments for cancer. Leveraging advanced research in oncology, the company aims to address unmet medical needs by offering novel therapeutic solutions that improve patient outcomes. OncoZenge operates within the biotechnology and pharmaceutical sectors, concentrating on the development of proprietary drug formulations and delivery systems designed to enhance the efficacy and safety of cancer therapies.
---
Technical Analysis
Biosergen AB
―
CombiGene AB
―
Modus Therapeutics Holding AB
―
Spago Nanomedical AB
―
Sprint Bioscience AB
―
---